Long-term follow up of a tuberous sclerosis patient: evaluation of anti-epileptic drugs and self- management support therapy
Penulis/Author
ANINDYA DIWASASRI (1); Prof. dr. Sunartini Sp.A(K), Ph.D. (2); Prof. dr. Retno Sutomo, Sp.A(K)., Ph.D. (3); Prof. Dr. Med. dr. Retno Danarti, Sp.KK(K). (4)
Tanggal/Date
6 2020
Kata Kunci/Keyword
Abstrak/Abstract
Tuberous sclerosis (TSC) (OMIM 191100) is an inherited, autosomal dominant disorder affecting multiple organ systems.1 A genetic mutation in one of the tumor suppressor gene (TSG) alleles causes tumor growth in various organ systems. Tuberous sclerosis can be found in people of all races, and does not differ in men and women, with an incidence 1 in 6,000 births and prevalence of 1 in 20,000.1-3 Although the prevalence is quite high, diagnosing this disorder is often difficult and delayed due to diverse disease manifestations and varied age at onset.
Rumpun Ilmu
Penyakit Kulit dan Kelamin
Bahasa Asli/Original Language
English
Level
Internasional
Status
Dokumen Karya
No
Judul
Tipe Dokumen
Aksi
1
Long-term follow up of a tuberous_sinta_dr_ Retno.pdf
[PAK] Full Dokumen
2
Akreditasi Paediatrica Indonesiana 2016-2021.pdf
3
Long-term follow up of a tuberous sclerosis patient evaluation of anti-epileptic drugs and self-management support therapy.pdf